Fertility drug for better embryos with genetic testing
Part of Women’s health & pregnancy clinical trials.
This trial is studying whether a specific fertility medication (hMG) helps improve embryo quality during IVF when you are also doing genetic testing of embryos. It may help you have better embryos for transfer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be having IVF with genetic testing of embryos (PGT-A).
- Your ovarian reserve must be within a certain range, based on AMH blood test or antral follicle count.
- Your BMI must be between 18.5 and 30.
- Both you and your partner must have normal chromosome tests.
- You cannot have had a previous cycle where you produced very few eggs.
- You cannot have certain other conditions, like PCOS, autoimmune disorders, or severe male factor infertility.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.